Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS, HELIOS-B Trial Investigators.

Open source

DOI
10.1056/nejmoa2409134
Published
2024-08-30
Container
N Engl J Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2409134,
  title = {Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.},
  author = {Fontana M and  Berk JL and  Gillmore JD and  Witteles RM and  Grogan M and  Drachman B and  Damy T and  Garcia-Pavia P and  Taubel J and  Solomon SD and  Sheikh FH and  Tahara N and  González-Costello J and  Tsujita K and  Morbach C and  Pozsonyi Z and  Petrie MC and  Delgado D and  Van der Meer P and  Jabbour A and  Bondue A and  Kim D and  Azevedo O and  Hvitfeldt Poulsen S and  Yilmaz A and  Jankowska EA and  Algalarrondo V and  Slugg A and  Garg PP and  Boyle KL and  Yureneva E and  Silliman N and  Yang L and  Chen J and  Eraly SA and  Vest J and  Maurer MS and  HELIOS-B Trial Investigators.},
  year = {2025},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2409134},
  url = {https://doi.org/10.1056/nejmoa2409134}
}

RIS

TY  - JOUR
TI  - Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.
AU  - Fontana M
AU  -  Berk JL
AU  -  Gillmore JD
AU  -  Witteles RM
AU  -  Grogan M
AU  -  Drachman B
AU  -  Damy T
AU  -  Garcia-Pavia P
AU  -  Taubel J
AU  -  Solomon SD
AU  -  Sheikh FH
AU  -  Tahara N
AU  -  González-Costello J
AU  -  Tsujita K
AU  -  Morbach C
AU  -  Pozsonyi Z
AU  -  Petrie MC
AU  -  Delgado D
AU  -  Van der Meer P
AU  -  Jabbour A
AU  -  Bondue A
AU  -  Kim D
AU  -  Azevedo O
AU  -  Hvitfeldt Poulsen S
AU  -  Yilmaz A
AU  -  Jankowska EA
AU  -  Algalarrondo V
AU  -  Slugg A
AU  -  Garg PP
AU  -  Boyle KL
AU  -  Yureneva E
AU  -  Silliman N
AU  -  Yang L
AU  -  Chen J
AU  -  Eraly SA
AU  -  Vest J
AU  -  Maurer MS
AU  -  HELIOS-B Trial Investigators.
PY  - 2025
JO  - N Engl J Med
DO  - 10.1056/nejmoa2409134
UR  - https://doi.org/10.1056/nejmoa2409134
ER  - 

APA

M, F., JL, B., JD, G., RM, W., M, G., B, D., T, D., P, G., J, T., SD, S., FH, S., N, T., J, G., K, T., C, M., Z, P., MC, P., D, D., P, V. D. M., A, J., A, B., D, K., O, A., S, H. P., A, Y., EA, J., V, A., A, S., PP, G., KL, B., E, Y., N, S., L, Y., J, C., SA, E., J, V., MS, M., & Investigators., H. T. (2025). Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.. N Engl J Med. https://doi.org/10.1056/nejmoa2409134

Source records